JP2013544265A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2013544265A5 JP2013544265A5 JP2013541272A JP2013541272A JP2013544265A5 JP 2013544265 A5 JP2013544265 A5 JP 2013544265A5 JP 2013541272 A JP2013541272 A JP 2013541272A JP 2013541272 A JP2013541272 A JP 2013541272A JP 2013544265 A5 JP2013544265 A5 JP 2013544265A5
- Authority
- JP
- Japan
- Prior art keywords
- dextran
- collar
- colloidal
- cardiopulmonary bypass
- priming solution
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 239000000243 solution Substances 0.000 claims description 19
- 238000001356 surgical procedure Methods 0.000 claims description 8
- 230000002016 colloidosmotic effect Effects 0.000 claims description 2
- FZWBNHMXJMCXLU-BLAUPYHCSA-N isomaltotriose Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@@H]1OC[C@@H]1[C@@H](O)[C@H](O)[C@@H](O)[C@@H](OC[C@@H](O)[C@@H](O)[C@H](O)[C@@H](O)C=O)O1 FZWBNHMXJMCXLU-BLAUPYHCSA-N 0.000 claims 9
- 229920002307 Dextran Polymers 0.000 claims 7
- 230000037452 priming Effects 0.000 claims 6
- 230000002612 cardiopulmonary effect Effects 0.000 claims 4
- 229940041984 dextran 1 Drugs 0.000 claims 3
- 229940119744 dextran 40 Drugs 0.000 claims 2
- 239000003855 balanced salt solution Substances 0.000 claims 1
- 239000012530 fluid Substances 0.000 claims 1
- QTBSBXVTEAMEQO-UHFFFAOYSA-M Acetate Chemical compound CC([O-])=O QTBSBXVTEAMEQO-UHFFFAOYSA-M 0.000 description 7
- 239000008280 blood Substances 0.000 description 2
- 210000004369 blood Anatomy 0.000 description 2
- 206010053567 Coagulopathies Diseases 0.000 description 1
- 230000000740 bleeding effect Effects 0.000 description 1
- 230000035602 clotting Effects 0.000 description 1
- 239000007924 injection Substances 0.000 description 1
- 238000002347 injection Methods 0.000 description 1
- 239000007788 liquid Substances 0.000 description 1
- 210000002700 urine Anatomy 0.000 description 1
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GBGB1020300.8A GB201020300D0 (en) | 2010-11-30 | 2010-11-30 | Product |
| GB1020300.8 | 2010-11-30 | ||
| PCT/EP2011/069524 WO2012072374A1 (en) | 2010-11-30 | 2011-11-07 | Priming solutions for cardiopulmonary bypass |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2013544265A JP2013544265A (ja) | 2013-12-12 |
| JP2013544265A5 true JP2013544265A5 (https=) | 2014-12-25 |
| JP6051164B2 JP6051164B2 (ja) | 2016-12-27 |
Family
ID=43500877
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2013541272A Active JP6051164B2 (ja) | 2010-11-30 | 2011-11-07 | 心肺バイパス用プライミング液 |
Country Status (10)
| Country | Link |
|---|---|
| US (1) | US8969323B2 (https=) |
| EP (1) | EP2646040B1 (https=) |
| JP (1) | JP6051164B2 (https=) |
| CN (1) | CN103228285B (https=) |
| DK (1) | DK2646040T3 (https=) |
| ES (1) | ES2575206T3 (https=) |
| GB (1) | GB201020300D0 (https=) |
| PL (1) | PL2646040T3 (https=) |
| RU (1) | RU2013127665A (https=) |
| WO (1) | WO2012072374A1 (https=) |
Families Citing this family (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CA3047360C (en) | 2017-01-17 | 2023-09-26 | Xvivo Perfusion Ab | Organ preservation and/or perfusion solutions |
| US11707600B2 (en) * | 2020-11-18 | 2023-07-25 | CardioDriven, Inc. | Level set calibration and assurance for pulmonary artery pressure catheterization |
| CN117481629B (zh) * | 2023-12-29 | 2024-03-26 | 成都水木医疗科技有限公司 | 一种多功能胶体渗透压仪及其测定方法和应用 |
Family Cites Families (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB1594697A (en) | 1977-04-19 | 1981-08-05 | Pharmacia Ab | Oligosaccharide compositions for parenteral use |
| SE8900586L (sv) | 1989-02-21 | 1990-08-22 | Pharmacia Ab | Komposition och foerfarande foer att foerhindra adhesion mellan kroppsvaevnader |
| US5702880A (en) | 1993-06-04 | 1997-12-30 | Biotime, Inc. | Blood substitute comprising 0-5 mM K+ |
| SE505499C2 (sv) * | 1995-12-15 | 1997-09-08 | Stiftelsen Facthor | Förvaringslösning för organ och vävnad eller delar därav från människor och djur innehållande kalcium och nitroglycerin, användning därav samt förfarande för förvaring därmed |
| US6794124B2 (en) * | 1995-12-15 | 2004-09-21 | Stiftelsen Facthor | Preservation solution |
| US5902800A (en) * | 1998-03-27 | 1999-05-11 | Glenpharma | Dextran formulations and method for treatment of inflammatory joint disorders |
-
2010
- 2010-11-30 GB GBGB1020300.8A patent/GB201020300D0/en not_active Ceased
-
2011
- 2011-11-07 PL PL11788089T patent/PL2646040T3/pl unknown
- 2011-11-07 EP EP11788089.8A patent/EP2646040B1/en active Active
- 2011-11-07 WO PCT/EP2011/069524 patent/WO2012072374A1/en not_active Ceased
- 2011-11-07 DK DK11788089.8T patent/DK2646040T3/en active
- 2011-11-07 RU RU2013127665/15A patent/RU2013127665A/ru not_active Application Discontinuation
- 2011-11-07 JP JP2013541272A patent/JP6051164B2/ja active Active
- 2011-11-07 ES ES11788089.8T patent/ES2575206T3/es active Active
- 2011-11-07 US US13/634,934 patent/US8969323B2/en active Active
- 2011-11-07 CN CN201180056991.XA patent/CN103228285B/zh active Active
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Dellinger | Cardiovascular management of septic shock | |
| Shekar et al. | Pharmacokinetic changes in patients receiving extracorporeal membrane oxygenation | |
| Bartorelli et al. | Contrast‐induced nephropathy | |
| EP2324871A3 (en) | Citrate anticoagulation system for extracorporeal blood treatments | |
| JP2017510334A5 (https=) | ||
| JP2014527025A5 (https=) | ||
| Mehta et al. | Pulmonary hypertension in various stages of chronic kidney disease in Indian patients | |
| Krawiec et al. | Impact of Pulsatile Flow on Hemodynamic Energy in a M edos D eltastream DP 3 Pediatric Extracorporeal Life Support System | |
| Lee et al. | A reproducible, clinically relevant, intensively managed, pig model of acute liver failure for testing of therapies aimed to prolong survival | |
| JP2013544265A5 (https=) | ||
| Johnston et al. | Novel leukocyte modulator device reduces the inflammatory response to cardiopulmonary bypass | |
| Guan et al. | Balanced ultrafiltration: inflammatory mediator removal capacity | |
| CN203469104U (zh) | 一种crrt血液透析管路 | |
| Kuriyama et al. | Sustained high-efficiency daily diafiltration using a mediator-adsorbing membrane (SHEDD-fA) in the treatment of patients with severe sepsis | |
| Simons et al. | Hypovolemia in extracorporeal life support can lead to arterial gaseous microemboli | |
| Cardenas Jr et al. | Percutaneous venovenous CO2 removal with regional anticoagulation in an ovine model | |
| CN205235040U (zh) | 一种基于贝朗血液净化机的血液灌流管路 | |
| Allen et al. | Bloodless surgery in a pediatric Jehovah’s Witness | |
| CN103228285B (zh) | 用于心肺转流术的预充液 | |
| WO2011131358A3 (de) | Verfahren und vorrichtung zur bestimmung des fistelflusses einer fistel für die dialysebehandlung | |
| Durandy et al. | An original versatile nonocclusive pressure‐regulated blood roller pump for extracorporeal perfusion | |
| Hothi et al. | Pediatric hemodialysis prescription, complications, and future directions | |
| Dhami et al. | In Vitro Comparison of the Delivery of Gaseous Microemboli and Hemodynamic Energy for a Diagonal and a Roller Pump During Simulated Infantile C ardiopulmonary B ypass Procedures | |
| Lee et al. | Hemodialysis using a valveless pulsatile blood pump | |
| Zhao et al. | Clinical application of pulsatile perfusion during cardiopulmonary bypass in pediatric heart surgery |